In addition, a recent study has reported that DNMT3A-mutated leukemia cells exhibit impaired PARP1 recruitment, p53 activation and increased DNA damage after being challenged by replication stress-induced medications [108]. The gene discussed is DNMT3A; the disease is leukemia.